Is Clindamycin Hydrochloride Capsule (Cleocin Hydrochloride) in shortage?
Clindamycin Hydrochloride Capsule is listed by FDA as being discontinued by at least one maker (updated Feb 25, 2026).
Every listed package
FDA tracks shortages per package. What each maker reports, most recently updated first:
- Cleocin Hydrochloride, Capsule, 150 mg (NDC 0009-0225-02)
Discontinuation of the manufacture of the drug
Maker contact: 844-646-4398
- Cleocin Hydrochloride, Capsule, 75 mg (NDC 0009-0331-02)
Discontinuation of the manufacture of the drug
Maker contact: 844-646-4398
- Cleocin Hydrochloride, Capsule, 300 mg (NDC 0009-0395-14)
Discontinuation of the manufacture of the drug
Maker contact: 844-646-4398
FDA recalls of Clindamycin Hydrochloride
Recalls can cause or worsen a shortage. These FDA drug recalls share an active ingredient with Clindamycin Hydrochloride Capsule:
- Glenmark Pharmaceuticals Inc., USA recalls Clindamycin Hydrochloride Capsules, USP, 300mg, 100-count bottles, Manufactured by: Glenmark Pharmaceuticals Limited,
- Cardinal Health Inc. recalls CLINDAMYCIN HYDROCHLORIDE CAPSULES, USP,150MG 100-count bottles, Rx Only, Manufactured by: Ohm Laboratories Inc. New
Clindamycin Hydrochloride Capsule shortage questions
Is Clindamycin Hydrochloride Capsule (Cleocin Hydrochloride) in shortage?
Clindamycin Hydrochloride Capsule is listed by FDA as being discontinued by at least one maker (updated Feb 25, 2026).
What should I do if I can’t get Clindamycin Hydrochloride Capsule?
Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.
Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.